Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability and safety of increasing doses of
primaquine in combination with artemether-lumefantrine in G6PD deficient males with an
asymptomatic P. falciparum malaria infection.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Centre national de recherche et de formation sur le paludisme University Medical Center Nijmegen
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine Primaquine